ACPU
INSM icon

Arrowgrass Capital Partners (US)’s Insmed INSM Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-85,122
Closed -$1.77M – 538
2015
Q1 		$1.77M Buy
+85,122
New +$1.5M 0.03% 267

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s INSM Position: Q2 2015 in Review

Arrowgrass Capital Partners (US) sold out of Insmed (INSM) in Q2 2015, closing a stake of 85,122 shares — an estimated $1.77M sold.

Arrowgrass Capital Partners (US) first reported a position in INSM in Q1 2015 and held it in 1 quarter. The position peaked at $1.77M in Q1 2015. 116 funds tracked by Wall St. Rank hold INSM as of Q2 2015.

  • Arrowgrass Capital Partners (US) reported no remaining Insmed position as of Q2 2015 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 85,122 Insmed shares in Q2 2015, an estimated $1.77M.
  • Arrowgrass Capital Partners (US) first reported a position in Insmed in Q1 2015 and held it in 1 quarter.
  • Arrowgrass Capital Partners (US)'s Insmed position peaked at $1.77M in Q1 2015.
  • 116 funds tracked by Wall St. Rank held Insmed as of Q2 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2015, filed 14 Aug 2015.